Program 29 September 2023

08.30-9.15 | Targeting defects in DNA repair in precision oncology | Sven Rottenberg
9.15-10.15 | Implementation of the Weight of Evidence Assessment of human carcinogenic risk assessment according to ICHS1B(R1) – presentations and discussion / Thomas Nolte, N.N., John Vahle.

10.15-10.45 | COFFEE BREAK - POSTERS – EXHIBITION

10.45-11.15 | Impuritites in Bx and Gene therapies, safety perspective | Helen Booler & Thierry Flandre
11.15-11.45 | Immunogenicity of AAV-based gene therapy and new generation biologics | Fraser McBlane & Hannah Morgan
11.45-12.15 | Safety in vitro assessment of biologics | Nadine Stokar

12.15-13.15 | Case Presentation

13.15-13.30 | Closing Ceremony